Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply

JAMA Neurol. 2017 Jul 1;74(7):872. doi: 10.1001/jamaneurol.2017.0566.
No abstract available

Publication types

  • Comment

MeSH terms

  • Albumins
  • Biomarkers
  • Guillain-Barre Syndrome*
  • Humans
  • Immunoglobulins, Intravenous*
  • Monitoring, Physiologic

Substances

  • Albumins
  • Biomarkers
  • Immunoglobulins, Intravenous